orbifloxacin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
antibacterials, nalidixic acid derivatives 5591 113617-63-3

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • orbifloxacin
  • orbax
  • NSC-758614
  • Molecular weight: 395.38
  • Formula: C19H20F3N3O3
  • CLOGP: 0.79
  • LIPINSKI: 0
  • HAC: 6
  • HDO: 2
  • TPSA: 72.88
  • ALOGS: -4.19
  • ROTB: 3

Drug dosage:

None

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
None FDA

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

None

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

SpeciesUseRelation
Cats Bacterial infections Indication
Dogs Bacterial infections Indication

🐶 Veterinary products

ProductApplicantIngredients
Orbax Tablets Intervet Inc. 1
Posatex Otic Suspension Intervet Inc. 3
Orbax Intervet Inc. 1

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
CHEMBL295433 ChEMBL_ID
C095163 MESH_SUPPLEMENTAL_RECORD_UI
DB11443 DRUGBANK_ID
017774 NDDF
C1507970 UMLSCUI
7025 INN_ID
725717002 SNOMEDCT_US
D08299 KEGG_DRUG
60605 PUBCHEM_CID
995897 RXNORM
660932TPY6 UNII

Pharmaceutical products:

None